One of the proteins localized in oncosomes, cytokeratin 18 (CK18), has been found to be highly prevalent (within the top fifth percentile) and was used in the creation of a test to detect oncosomes in tissues and circulatory of both human and mouse prostate cancer patients. This evidence concerns the gene KRT18 and prostate cancer.